ClinicalTrials.Veeva

Menu

ECMO: Optimization of Its Use

R

Renzo Loyaga Rendon

Status

Terminated

Conditions

Extracorporeal Membrane Oxygenation Complication

Study type

Observational

Funder types

Other

Identifiers

NCT02280460
2014-194

Details and patient eligibility

About

To create a local registry for ECMO patients.

Full description

To create a local registry of retrospective and prospective patients on ECMO at Spectrum Health, Butterworth campus in order to optimize the use of ECMO therapy and to create algorithms to estimate the prognosis. ECMO patients will be compared to a control group of patients. Patient mortality will be assessed in-house, at 48 hours, 3 months, and 1 year after the start of ECMO therapy.

Enrollment

921 patients

Sex

All

Ages

18+ years old

Volunteers

No Healthy Volunteers

Inclusion criteria

  • Age >18
  • requiring ECMO. For the control,Patients without ECMO admited to ICU.

Exclusion criteria

  • Age<18
  • Known prisoner of the state

Trial design

921 participants in 2 patient groups

VA ECMO
Description:
Patients who are placed on VA ECMO.
VV ECMO
Description:
Patients who are placed on VV ECMO.

Trial contacts and locations

1

Loading...

Central trial contact

Dana Marsy, MPH; Catherine E Kelty, PhD

Data sourced from clinicaltrials.gov

Clinical trials

Find clinical trialsTrials by location
© Copyright 2026 Veeva Systems